News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,760 Results
Type
Article (1630)
Company Profile (11)
Press Release (68119)
Section
Business (29688)
Career Advice (41)
Deals (4724)
Drug Delivery (1)
Drug Development (7950)
Employer Resources (9)
FDA (1394)
Job Trends (1890)
News (42063)
Policy (2347)
Tag
Academia (134)
Accelerated approval (3)
Allergies (14)
Alliances (2485)
ALS (7)
Alzheimer's disease (163)
Antibody-drug conjugate (ADC) (29)
Approvals (1480)
Artificial intelligence (18)
Autoimmune disease (13)
Automation (1)
Bankruptcy (14)
Best Places to Work (1867)
BIOSECURE Act (1)
Biosimilars (18)
Biotechnology (5)
Bladder cancer (38)
Brain cancer (3)
Breast cancer (114)
Cancer (616)
Cardiovascular disease (50)
Career advice (36)
Career pathing (1)
CAR-T (31)
Cell therapy (63)
Cervical cancer (4)
Clinical research (7502)
Collaboration (88)
Compensation (72)
Complete response letters (2)
COVID-19 (179)
CRISPR (6)
C-suite (26)
Cystic fibrosis (16)
Data (897)
Depression (10)
Diabetes (63)
Diagnostics (703)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (3)
Duchenne muscular dystrophy (13)
Earnings (27504)
Editorial (1)
Employer branding (2)
Employer resources (8)
Events (9305)
Executive appointments (28)
FDA (1896)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (73)
Gene editing (14)
Generative AI (2)
Gene therapy (40)
GLP-1 (101)
Government (230)
Grass and pollen (1)
Guidances (248)
Healthcare (2192)
HIV (10)
Huntington's disease (1)
IgA nephropathy (23)
Immunology and inflammation (23)
Immuno-oncology (2)
Indications (13)
Infectious disease (206)
Inflammatory bowel disease (16)
Inflation Reduction Act (2)
Influenza (11)
Intellectual property (17)
Interviews (4)
IPO (3604)
Job creations (147)
Job search strategy (33)
Kidney cancer (5)
Labor market (8)
Layoffs (32)
Leadership (1)
Legal (395)
Liver cancer (7)
Longevity (1)
Lung cancer (89)
Lymphoma (72)
Machine learning (2)
Management (2)
Manufacturing (34)
MASH (18)
Medical device (1683)
Medtech (1688)
Mergers & acquisitions (1213)
Metabolic disorders (115)
Multiple sclerosis (16)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (10)
Neuroscience (257)
NextGen: Class of 2026 (425)
Non-profit (264)
Now hiring (1)
Obesity (34)
Opinion (7)
Ovarian cancer (12)
Pain (13)
Pancreatic cancer (19)
Parkinson's disease (26)
Partnered (1)
Patents (26)
Patient recruitment (14)
Peanut (7)
People (2163)
Pharmaceutical (4)
Pharmacy benefit managers (4)
Phase I (1736)
Phase II (2981)
Phase III (3254)
Pipeline (1356)
Policy (8)
Postmarket research (346)
Preclinical (545)
Press Release (16)
Prostate cancer (17)
Psychedelics (1)
Radiopharmaceuticals (26)
Rare diseases (75)
Real estate (198)
Recruiting (6)
Regulatory (2072)
Reports (11)
Research institute (130)
Resumes & cover letters (1)
Rett syndrome (4)
RSV (15)
Schizophrenia (17)
Series A (7)
Series B (8)
Service/supplier (1)
Sickle cell disease (12)
Special edition (2)
Spinal muscular atrophy (8)
Sponsored (2)
Startups (124)
Stomach cancer (1)
Supply chain (8)
Tariffs (2)
Vaccines (81)
Venture capital (6)
Weight loss (20)
Women's health (9)
Date
Today (16)
Last 7 days (49)
Last 30 days (186)
Last 365 days (4529)
2026 (49)
2025 (4512)
2024 (5191)
2023 (6111)
2022 (6895)
2021 (7045)
2020 (5971)
2019 (4493)
2018 (3342)
2017 (3174)
2016 (2541)
2015 (3035)
2014 (2023)
2013 (1282)
2012 (1541)
2011 (1806)
2010 (1718)
Location
Africa (38)
Alabama (5)
Alaska (1)
Arizona (21)
Asia (4017)
Australia (469)
California (1484)
Canada (371)
China (123)
Colorado (61)
Connecticut (62)
Delaware (66)
Europe (10155)
Florida (244)
Georgia (55)
Idaho (4)
Illinois (86)
India (4)
Indiana (92)
Japan (63)
Kansas (13)
Kentucky (14)
Louisiana (6)
Maine (19)
Maryland (186)
Massachusetts (1015)
Michigan (63)
Minnesota (89)
Missouri (20)
Montana (11)
Nebraska (6)
Nevada (11)
New Hampshire (11)
New Jersey (682)
New Mexico (1)
New York (568)
North Carolina (175)
North Dakota (1)
Northern California (808)
Ohio (24)
Oklahoma (1)
Pennsylvania (281)
South America (67)
Southern California (564)
Tennessee (23)
Texas (228)
United States (5777)
Utah (45)
Virginia (36)
Washington D.C. (15)
Washington State (189)
Wisconsin (10)
69,760 Results for "73".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
Jacobio discovered JAB-23E73, which is designed to treat several KRAS mutation subtypes, and is testing the therapy in multiple Phase I trials.
December 22, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Compounding Pharmacies Market Size to Hit USD 33.73 Billion by 2034
June 23, 2025
·
1 min read
BioMidwest
CinRx Pharma Announces Additional $73 Million Financing
CinRx Pharma today announced the closing of a $73 million financing, bringing the total funds raised to $176 million.
May 30, 2024
·
4 min read
Layoffs
Lyell Cuts 73 Employees as Part of LA Site Closure
After moving the manufacturing of a CAR T drug that was part of its ImmPACT Bio acquisition to Washington, Lyell Immunopharma is closing its Los Angeles manufacturing facility, eliminating dozens of jobs there.
April 7, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Diabetes Care Market Size to worth to Reach USD 62.73 Billion by 2032, Coherent Market Insights
May 8, 2025
·
1 min read
Gene editing
Arbor Raises $73.5M To Ride Out Gene Editing’s ‘Gartner Hype Cycle’
The gene therapy world is in turmoil, but Arbor, armed with more than $1 billion in partnerships and raises, is going forward.
March 18, 2025
·
4 min read
·
Dan Samorodnitsky
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Aires Announces Record Q3/2025 Revenue of $7.4 Million and 61% YoY Sales Growth and Discusses Factors Related to Liquidity and Continuing Operations
• Gross Profit increased 73% YoY • Gross Margin increased 500 basis points to 68% • Adjusted EBITDA loss reported at $1.46M vs $1.17M in year-ago quarter • Near-term business objectives are focused on preserving cash, stabilizing operations, and securing the financial resources required to support continuity of operations
November 26, 2025
·
16 min read
Press Releases
North America Point of Care Diagnostics Market Size to Hit USD 34.73 Billion by 2033
February 27, 2025
·
1 min read
Press Releases
Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing Therapeutics
March 18, 2025
·
4 min read
1 of 6,976
Next
